{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:56:45Z","timestamp":1789898205400,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY011309"],"award-info":[{"award-number":["R01-EY011309"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY022445"],"award-info":[{"award-number":["R01-EY022445"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007745","name":"Massachusetts Lions Eye Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007732","name":"American Macular Degeneration Foundation, Northampton, Massachusetts, USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ajo.2018.10.022","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:41:43Z","timestamp":1540946503000},"page":"223-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals"],"prefix":"10.1016","volume":"198","author":[{"given":"Johanna M.","family":"Seddon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9827","key":"10.1016\/j.ajo.2018.10.022_bib1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2018.10.022_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.12.004","article-title":"Nature and nurture- genes and environment- predict onset and progression of macular degeneration","volume":"40","author":"Sobrin","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"14","key":"10.1016\/j.ajo.2018.10.022_bib3","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1167\/iovs.17-23544","article-title":"Macular degeneration epidemiology: nature-nurture, lifestyle factors, genetic risk, and gene-environment interactions \u2013 the Weisenfeld Award Lecture","volume":"58","author":"Seddon","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.1941.00870100042005","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib5","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archopht.1988.01060140711040","article-title":"Assessment of visual function in patients with age-related macular degeneration and low visual acuity","volume":"106","author":"Alexander","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9394(99)00169-5","article-title":"Influence of age-related maculopathy on visual functioning and health-related quality of life","volume":"128","author":"Mangione","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archopht.116.4.514","article-title":"The Psychosocial impact of macular degeneration","volume":"116","author":"Williams","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"14","key":"10.1016\/j.ajo.2018.10.022_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajo.2018.10.022_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archopht.123.3.321","article-title":"The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"5720","key":"10.1016\/j.ajo.2018.10.022_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ajo.2018.10.022_bib14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng1873","article-title":"Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration","volume":"38","author":"Maller","year":"2006","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.ajo.2018.10.022_bib15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng2131","article-title":"Variation in complement factor 3 is associated with risk of age-related macular degeneration","volume":"39","author":"Maller","year":"2007","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ajo.2018.10.022_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.molimm.2014.06.032","article-title":"Genetic variants in the complement system predisposing to age-related macular degeneration: a review","volume":"61","author":"Schramm","year":"2014","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1016\/j.ajo.2018.10.022_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.291.6.704","article-title":"Association between C-reactive protein and age-related macular degeneration","volume":"291","author":"Seddon","year":"2004","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ajo.2018.10.022_bib19","first-page":"5276","article-title":"Protective coding variants in CFH and PELI3 and a variant near CTRB1 are associated with age-related macular degeneration\u2020","volume":"25","author":"Yu","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.ajo.2018.10.022_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.938","article-title":"Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population","volume":"43","author":"Arakawa","year":"2011","journal-title":"Nat Genet"},{"issue":"16","key":"10.1016\/j.ajo.2018.10.022_bib21","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1073\/pnas.0912019107","article-title":"Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)","volume":"107","author":"Neale","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ng.2578","article-title":"Seven new loci associated with age-related macular degeneration","volume":"45","author":"Fritsche","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ajo.2018.10.022_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/444437","article-title":"Susceptibility genes for age-related maculopathy on chromosome 10q26","volume":"77","author":"Jakobsdottir","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.ajo.2018.10.022_bib24","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.0912702107","article-title":"Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.ajo.2018.10.022_bib25","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/hmg\/ddr270","article-title":"Common variants near FRK\/COL10A1 and VEGFA are associated with advanced age-related macular degeneration","volume":"20","author":"Yu","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.ajo.2018.10.022_bib26","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.976","article-title":"A rare penetrant mutation in CFH confers high risk of age-related macular degeneration","volume":"43","author":"Raychaudhuri","year":"2011","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ajo.2018.10.022_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaophthalmol.2015.0814","article-title":"Phenotypic characterization of complement factor H R1210C rare genetic variant in age-related macular degeneration","volume":"133","author":"Ferrara","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ejhg.2009.185","article-title":"Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach","volume":"18","author":"Sobrin","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"19","key":"10.1016\/j.ajo.2018.10.022_bib29","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1093\/hmg\/ddu226","article-title":"Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration","volume":"23","author":"Yu","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib30","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1167\/iovs.15-17432","article-title":"Rare variants in the functional domains of complement factor H are associated with age-related macular degeneration","volume":"56","author":"Triebwasser","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2018.10.022_bib31","doi-asserted-by":"crossref","first-page":"31531","DOI":"10.1038\/srep31531","article-title":"Mapping rare, deleterious mutations in Factor H: association with early onset, drusen burden, and lower antigenic levels in familial AMD","volume":"6","author":"Wagner","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib32","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ng.2741","article-title":"Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration","volume":"45","author":"Seddon","year":"2013","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.ajo.2018.10.022_bib33","first-page":"3861","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1016\/j.ajo.2018.10.022_bib34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.297.16.1793","article-title":"Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration","volume":"297","author":"Seddon","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ajo.2018.10.022_bib35","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1167\/iovs.08-3064","article-title":"Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables","volume":"50","author":"Seddon","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib36","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.ophtha.2011.04.029","article-title":"Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors","volume":"118","author":"Seddon","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2018.10.022_bib37","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1167\/iovs.11-8657","article-title":"Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models","volume":"53","author":"Yu","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamaophthalmol.2013.2578","article-title":"Validation of a prediction algorithm for progression to advanced macular degeneration subtypes","volume":"131","author":"Seddon","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib39","doi-asserted-by":"crossref","first-page":"e87047","DOI":"10.1371\/journal.pone.0087047","article-title":"Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration","volume":"9","author":"Seddon","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib40","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1167\/iovs.14-15841","article-title":"Risk prediction for progression of macular degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates","volume":"56","author":"Seddon","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ajo.2010.08.015","article-title":"ARMS2\/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration","volume":"151","author":"Sobrin","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.10.022_bib42","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2012.03.014","article-title":"Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes","volume":"119","author":"Sobrin","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajo.2018.10.022_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jclinepi.2017.11.013","article-title":"Poor performance of clinical prediction models: the harm of commonly applied methods","volume":"98","author":"Steyerberg","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ajo.2018.10.022_bib46","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3945\/ajcn.115.111047","article-title":"Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study","volume":"102","author":"Merle","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.ajo.2018.10.022_bib47","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-308624","article-title":"Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis","volume":"100","author":"Seddon","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.10.022_bib48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3945\/ajcn.115.117606","article-title":"Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study","volume":"103","author":"Merle","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib49","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1167\/iovs.17-21673","article-title":"Associations between vitamin D intake and progression to incident advanced age-related macular degeneration","volume":"58","author":"Merle","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2018.10.022_bib50","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1167\/iovs.17-21696","article-title":"Optical coherence tomography features preceding the onset of advanced age-related macular degeneration","volume":"58","author":"Ferrara","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2018.10.022_bib51","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2018.10.022_bib52","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014an extension of the Modified Airlie House Classification: ETDRS Report Number 10","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ophtha.2005.11.001","article-title":"Evaluation of the clinical age-related maculopathy staging system","volume":"113","author":"Seddon","year":"2006","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib54","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.10.022_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ajo.2018.10.022_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/09286586.2012.674614","article-title":"Regression methods when the eye is the unit of analysis","volume":"19","author":"Glynn","year":"2012","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib57","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1541-0420.2008.01062.x","article-title":"Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models","volume":"65","author":"Rosner","year":"2009","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-013-2719-3","article-title":"Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study","volume":"142","author":"Rosner","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib63","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2013.07.039","article-title":"CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration","volume":"120","author":"Awh","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2018.10.022_bib64","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2012.10.020","article-title":"Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy","volume":"120","author":"Reynolds","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2018.10.022_bib65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ophtha.2014.07.049","article-title":"Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study","volume":"122","author":"Awh","year":"2015","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2018.10.022_bib66","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jamaophthalmol.2016.3519","article-title":"Histopathological insights into choroidal vascular loss in clinically documented cases of age-related macular degeneration","volume":"134","author":"Seddon","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2018.10.022_bib67","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1167\/iovs.09-3928","article-title":"Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes","volume":"50","author":"Reynolds","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2018.10.022_bib68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/bjophthalmol-2015-306621","article-title":"Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration","volume":"100","author":"Wu","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2018.10.022_bib69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation","volume":"286","author":"D\u2019Agostino","year":"2001","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ajo.2018.10.022_bib70","doi-asserted-by":"crossref","first-page":"e1001492","DOI":"10.1371\/journal.pmed.1001492","article-title":"Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50\u00a0y or older: derivation and validation from population-based cohort studies","volume":"10","author":"Pfeiffer","year":"2013","journal-title":"PLoS Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418306172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418306172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:39:10Z","timestamp":1757597950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418306172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":69,"alternative-id":["S0002939418306172"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.10.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}